Seller record · Telehealth service

CoreAge Rx

By Peptide Alliance, Editorial publisherRecorded August 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No page presents a filling pharmacy; a pharmacy name appears only in the operator's own privacy-policy DBA. 1 more criterion also fails; see the table below.

At a glance

CoreAge RxTelehealth service

6/8criteria passed
Price
Semaglutide from $99, tirzepatide from $149 a month
Sells
semaglutide, tirzepatide, microdosed GLP-1s, and 2 more
FDA letters
None on file

Partner link. The site earns a commission on care started through it. Funding

Visit CoreAge RxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded GLP-1 drugs, NAD+, and sermorelin. It names its physicians and prints every price, and it names no filling pharmacy.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSCoreAge Rx's FAQ
S2Prescription gatingPASSCoreAge Rx's FAQ
S3Pharmacy identificationFAILCoreAge Rx's privacy page
S4Compounding disclosurePASSCoreAge Rx's important safety information for compounded semaglutide page
S5Analytical documentationFAILCoreAge Rx's FAQ
S6Business addressPASSCoreAge Rx's privacy page
S7Price disclosurePASSCoreAge Rx's website
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date. A row that was re-checked later states its own date.

S1PASSThe site states US board-certified physicians evaluate orders; two named with state license numbers.Source: CoreAge Rx's FAQ.
S2PASSA provider approves each prescription; unapproved orders are refunded in full.Source: CoreAge Rx's FAQ.
S3FAILNo page presents a filling pharmacy; a pharmacy name appears only in the operator's own privacy-policy DBA.Source: CoreAge Rx's privacy page.
S4PASSA dedicated safety page explains compounded semaglutide and its non-approved status.Source: CoreAge Rx's important safety information for compounded semaglutide page.
S5FAILNo certificate, lot number or testing claim appears on the site. Home, questions, about, privacy and the compounded-semaglutide safety page carry none.Source: CoreAge Rx's FAQ · read September 2026.
S6PASSRegistered business address stated in Sheridan, Wyoming; a registered-agent suite.Source: CoreAge Rx's privacy page.
S7PASSPrices printed on the homepage: semaglutide from $99, tirzepatide from $149 monthly.Source: CoreAge Rx's website.
S8PASSNo FDA warning letter names the entity, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide, tirzepatide, microdosed GLP-1s, NAD+ injectable and nasal, sermorelin.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+

Partner link. The site earns a commission on care started through it. Funding.

Visit CoreAge Rx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.